Notícias GeoVax Labs Inc - GOVX | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
GeoVax Labs Inc (GOVX)
GeoVax Labs Inc (GOVX) Notícias

GeoVax Labs Inc (GOVX)

1,71

-0,02

(-1,16%)

No fechamento: 13 Fevereiro 6:00PM

Atrasado por 15 minutos

1,69

-0,02

( -1,17% )

Após o horário de negociação: 8:00PM

Atrasado por 15 minutos

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

GeoVax to Participate in Upcoming Investor Conferences in September

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Registration is Now Open for Tribe Public’s Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab’s CEO

GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market

Form 4 - Statement of changes in beneficial ownership of securities

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições